Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)

E. K. Akpek, K. Karadayl, J. K. Cheetham

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial [2] (multiple letters)'. Together they form a unique fingerprint.